Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors

Journal of Neuro-Oncology

Volumn 67, Issue 1-2, 2004, Pages 201-207

  Schmidt, Meic H ^a   Meyer, Glenn A ^b   Reichert, Kenneth W ^b   Cheng, Joseph ^b   Krouwer, Hendrikus G ^b   Ozker, Kutlan ^b   Whelan, Harry T ^b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

Brain tumors; Laser; Light emitting diodes; Photodynamic therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BENZOPORPHYRIN DERIVATIVE; GLASS FIBER; INDIUM 111; PHOTOFRIN; PHOTOSENSITIZING AGENT; STEROID; UNCLASSIFIED DRUG; VISUDINE;

ADOLESCENT; ADULT; ARTICLE; ATAXIA; BRAIN TISSUE; BRAIN TUMOR; CANCER CONTROL; CEREBELLUM TENTORIUM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIECTOMY; CRANIOTOMY; DEVICE; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIZATION; DRUG TOLERABILITY; DRUG TUMOR LEVEL; DRUG UPTAKE; DYE LASER; EQUIPMENT DESIGN; FACIAL NERVE PARALYSIS; FIBER OPTICS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERSTITIUM; LASER; LIGHT EMITTING DIODE; LIGHT EXPOSURE; MALIGNANT NEOPLASTIC DISEASE; MAXIMUM PERMISSIBLE DOSE; MEDICAL TECHNOLOGY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; POSTERIOR FOSSA; QUANTITATIVE ANALYSIS; RADIATION DOSE; TIME; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; DIHEMATOPORPHYRIN ETHER; HUMANS; INFANT; LASERS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TISSUE DISTRIBUTION;

EID: 1842431906     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000021804.50002.85     Document Type: Article

References (30)

1. Agostinis P, Vantieghem A, Merlevede W, de Witt PA: Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34: 221-241, 2002
2. Barta DJ, Tibbitts TW, Bula RJ, Morrow RC: Evaluation of light emitting diode characteristics for a space-based plant irradiation source. Adv Space Res 12: 141-149, 1992
3. Bula RJ, Morrow RC, Tibbitts TW, Barta DJ, Ignatius RW, Martin TS: Light-emitting diodes as a radiation source for plants. HortScience 26: 203-205, 1991
4. Cheng MK, McKean J, Boisvert D, Tulip J, Mielke BW: Effects of photoradiation therapy on normal rat brain. Neurosurgery 15: 804-810, 1984
5. Couldwell WT, Gopalakrishna R, Hinton DR, He S, Weiss MH, Law RE, Apuzzo ML, Law RE: Hypericin: a potential antiglioma therapy. Neurosurgery 35: 705-709; discussion 709-710, 1994
6. Dereski MO, Madigan L, Chopp M: The effect of hypothermia and hyperthermia on photodynamic therapy of normal brain. Neurosurgery 36: 141-145; discussion 145-146, 1995
7. Elias Z, Powers SK, Atstupenas E, Brown JT: Hyperthermia from interstitial laser irradiation in normal rat brain. Lasers Surg Med 7: 370-375, 1987
8. Goetz C, Hasan A, Stummer W, Heimann A, Kempski O: Experimental research photodynamic effects in perifocal, oedematous brain tissue. Acta Neurochir (Wien) 144: 173-179; discussion 179, 2002
9. Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS: Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 26: 248-254, 1990
10. Kirollos RW, Marks PV, Igbaseimokumo U, Chakrabarty A: A preliminary experimental in vivo study of the effect of photodynamic therapy on human pituitary adenoma implanted in mice. Br J Neurosurg 12: 140-145, 1998
11. Krishnamurthy S, Powers SK, Witmer P, Brown T: Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. Lasers Surg Med 27: 224-234, 2000
12. Laws ER Jr, Cortese DA, Kinsey JH, Eagan RT, Anderson RE: Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study. Neurosurgery 9: 672-678, 1981
13. Laws ER Jr, Wharen RE, Anderson RE: The treatment of brain tumors by photoradiation. In: Pluchino F, Giovanni B (eds) Advanced Technology in Neurosurgery. Springer, Heidelberg, 1988, pp 46-60
14. Marks PV, Belchetz PE, Saxena A, Igbaseimokumo U, Thomson S, Nelson M, Stringer MR, Holroyd JA, Brown SB: Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial - an early report. Br J Neurosurg 14: 317-325, 2000
15. Muller PJ, Wilson BC: Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg 14: 263-270, 1996
16. Muller PJ, Wilson BC: Photodynamic therapy for recurrent supratentorial gliomas. Semin Surg Oncol 11: 346-354, 1995
17. Muller PJ, Wilson BC: Photodynamic therapy of malignant brain tumors. Can J Neurol Sci 17: 193-198, 1990
18. Muller PJ, Wilson BC: Photodynamic therapy of malignant primary brain tumors: clinical effects, post-operative ICP, and light penetration of the brain. Photochem Photobiol 46: 929-935, 1987
19. Origitano TC, Caron MJ, Reichman OH: Photodynamic therapy for intracranial neoplasms. Literature review and institutional experience. Mol Chem Neuropathol 21: 337-352, 1994
20. Origitano TC, Karesh SM, Henkin RE, Halama JR, Reichman OH: Photodynamic therapy for intracranial neoplasms: investigations of photosensitizer uptake and distribution using indium-111 Photofrin®-II single photon emission computed tomography scans in humans with intracranial neoplasms. Neurosurgery 32: 357-363; discussion 363-364, 1993
21. Origitano TC, Reichman OH: Photodynamic therapy for intracranial neoplasms: development of an image-based computer-assisted protocol for photodynamic therapy of intracranial neoplasms. Neurosurgery 32: 587-595; discussion 595-596, 1993
22. Popovic EA, Kaye AH, Hill JS: Photodynamic therapy of brain tumors. Semin Surg Oncol 11: 335-345, 1995
23. Powers SK, Cush SS, Walstad DL, Kwock L: Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery 29: 688-695; discussion 695-696, 1991
24. Schmidt MH, Bajic DM, Reichert KW II, Martin TS, Meyer GA, Whelan HT: Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery 38: 552-556; discussion 556-557, 1996
25. Schmidt MH, Reichert KW II, Ozker K, Meyer GA, Donohoe DL, Bajic DM, Whelan NT, Whelan HT: Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors. Pediatric Neurosurg 30: 225-231, 1999
26. Stummer W, Hassan A, Kempski O, Goetz C: Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. J Photochem Photobiol B 36: 179-181, 1996
27. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93: 1003-1013, 2000
28. Whelan HT, Kras LH, Ozker K, Bajic D, Schmidt MH, Liu Y, Trembath LA, Uzum F, Meyer GA, Segura AD, David Collier B: Selective incorporation of 111 In-labeled PHOTOFRIN® by glioma tissue in vivo. J Neurooncol 22: 7-13, 1994
29. Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA: The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. J Neurosurg 79: 562-568, 1993
30. Zhang W, Law RE, Hinton DR, Couldwell WT: Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett 120: 31-38, 1997